Compumedics (ASX: CMP) — Perfil da empresa, notícias e dados financeiros
Compumedics is a global medical device company specializing in the development, manufacture, and commercialization of diagnostic technologies for sleep disorders, neurological monitoring, brain research, and ultrasonic blood flow evaluation.
Compumedics
Compumedics is a global medical device company specializing in the development, manufacture, and commercialization of diagnostic technologies for sleep disorders, neurological monitoring, brain research, and ultrasonic blood flow evaluation. Founded in Australia, the company designs advanced hardware amplifiers, specialized electrodes, and cloud-enabled laboratory management software used by hospitals, clinical laboratories, universities, and research institutions worldwide. Its core business divisions encompass polysomnography systems for sleep medicine, electroencephalography platforms for clinical neurology, Neuroscan high-channel brain research tools, DWL transcranial Doppler sonography devices, and wearable health-monitoring sensors designed for clinical trials and remote patient monitoring.
Resumo
Operações
Produtos e/ou serviços de Compumedics
- Sleep Diagnostics: In-lab and ambulatory sleep diagnostic systems, including polysomnography hardware and home sleep testing devices, record physiological parameters to assist clinicians in evaluating sleep apnea and other sleep-wake disorders across healthcare settings.
- Neurology Diagnostics: High-definition electroencephalography systems and long-term monitoring equipment capture continuous neurological activity in routine clinical environments, intensive care units, and specialized epilepsy monitoring units to support diagnostic evaluations.
- Brain Research Systems: High-density electroencephalography amplifiers and advanced source localization software assist academic and clinical researchers in conducting cognitive neuroscience research, neuroimaging studies, multimodal signal integration, and complex brain mapping applications.
- Ultrasonic Blood Flow Monitoring: Transcranial Doppler sonography hardware and diagnostic systems utilize ultrasound technology for non-invasive measurement and continuous real-time assessment of cerebral blood flow velocity in stroke, vascular, and critical care patients.
- Diagnostic Data Management Software: Integrated laboratory management software platforms enable multi-site healthcare facilities to score, process, archive, and securely manage diagnostic sleep and neurological patient data across networked cloud infrastructure.
- Wearable Medical Technology: Compact wearable sensor technologies and cloud-connected software solutions perform continuous sleep quality monitoring and collect biometric data for direct-to-consumer health tracking, medical trial support, and remote patient monitoring.
equipe executiva do Compumedics
- David BurtonFounder, Executive Chairman & CEO
- David Francis LawsonCFO, Company Secretary & Executive Director
- Warwick FreemanChief Technology Officer
- Kerry Trent HubickLegal Counsel and Trademark, Patent & General Legal Attorney
- Michael StoneChief Commercial Officer - US operations
Últimas notícias sobre a Compumedics
Comunicados recentes
O que a Compumedics (CMP) comunicou ao mercado, do mais recente para o mais antigo.
- Appendix 4G
- Corporate Governance Statement
- Proxy Form
- Notice of Annual General Meeting
Histórico de dividendos
Dividendos por ação pagos pela Compumedics, por ano fiscal.
| Ano fiscal | Intermediário | Final | Especial | Total |
|---|---|---|---|---|
| FY2024 | — | — | — | $0.4500 |
| FY2023 | — | — | — | $0.6000 |
| FY2022 | — | — | — | $1.1700 |
| FY2021 | — | — | — | $2.8800 |
| FY2020 | — | — | — | $2.8800 |
Principais indicadores financeiros
Resultados divulgados pela Compumedics.
- Cap. de mercado
- 46,9 mi
- Receita (TTM)
- 61,9 mi
- P/L
- —
- LPA (diluído, TTM)
- 0.0
- Dividend yield
- —
- Margem de lucro
- 0.4%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 60,3 mi | 1,8 mi | 214 mil | |
| 51 mi | 714 mil | -1,3 mi | |
| 49,7 mi | -812 mil | -338 mil | |
| 42,4 mi | -3,5 mi | -6,1 mi |